TREK1 Neurons

Introduction

<table class=“infobox infobox-cell”> <tr> <th class=“infobox-header” colspan=“2”>TREK1 Neurons</th> </tr> <tr> <td class=“label”>Gene Symbol</td> <td>KCNK2</td> </tr> <tr> <td class=“label”>Protein Name</td> <td>TREK1 (TWIK-Related Potassium Channel 1)</td> </tr> <tr> <td class=“label”>Channel Type</td> <td>Two-pore domain potassium channel (K2P)</td> </tr> <tr> <td class=“label”>Location</td> <td>Cortex, hippocampus, thalamus, dorsal root ganglion, spinal cord</td> </tr> <tr> <td class=“label”>Cell Types</td> <td>Pyramidal neurons, interneurons, DRG neurons, astrocytes</td> </tr> <tr> <td class=“label”>Primary Neurotransmitter</td> <td>Depends on neuron type (glutamate, GABA)</td> </tr> <tr> <td class=“label”>Key Markers</td> <td>KCNK2, KCNK4 (TRAAK)</td> </tr> <tr> <td class=“label”>Stimulus</td> <td>Effect</td> </tr> <tr> <td class=“label”>Membrane stretch</td> <td>Activation</td> </tr> <tr> <td class=“label”>Temperature</td> <td>Activation</td> </tr> <tr> <td class=“label”>pH (acidosis)</td> <td>Activation</td> </tr> <tr> <td class=“label”>Volatile anesthetics</td> <td>Activation</td> </tr> <tr> <td class=“label”>Voltage</td> <td>Weak voltage dependence</td> </tr> <tr> <td class=“label”>Phosphorylation</td> <td>Modulation</td> </tr> <tr> <td class=“label”>Strategy</td> <td>Compound</td> </tr> <tr> <td class=“label”>Activators</td> <td>ML335, ML335</td> </tr> <tr> <td class=“label”>Activators</td> <td>Volatile anesthetics</td> </tr> <tr> <td class=“label”>Inhibitors</td> <td>Spadin</td> </tr> </table>

TREK1 (TWIK-Related Potassium Channel 1), encoded by the KCNK2 gene, is a member of the two-pore domain potassium (K2P) channel family. These channels provide background leak potassium conductance that regulates neuronal excitability, resting membrane potential, and cellular responses to various stimuli. TREK1-expressing neurons are widely distributed throughout the central and peripheral nervous systems and play critical roles in neuroprotection, pain transduction, mood regulation, and responses to metabolic stress. This page provides comprehensive coverage of TREK1 neurons in normal function and neurodegeneration. [@bagriantsev2011]

Overview

flowchart TD
    TREK1["TREK1"] -->|"regulates"| Blood_Brain_Barrier_Function["Blood-Brain Barrier Function"]
    TREK1["TREK1"] -->|"inhibits"| Lymphocyte_Migration["Lymphocyte Migration"]
    TREK1["TREK1"] -->|"expressed in"| Brain_Endothelial_Cells["Brain Endothelial Cells"]
    TREK1["TREK1"] -->|"involved in"| Depression["Depression"]
    TREK1["TREK1"] -->|"involved in"| Pain["Pain"]
    TREK1["TREK1"] -->|"involved in"| Neurodegenerative_Damage["Neurodegenerative Damage"]
    TREK1["TREK1"] -->|"regulates"| MEMBRANE_POTENTIAL["MEMBRANE_POTENTIAL"]
    TREK1["TREK1"] -->|"regulates"| CELLULAR_EXCITABILITY["CELLULAR_EXCITABILITY"]
    TREK1["TREK1"] -->|"regulates"| POTASSIUM_LEAK["POTASSIUM_LEAK"]
    TREK1["TREK1"] -->|"associated with"| TEMPERATURE_SENSITIVITY["TEMPERATURE_SENSITIVITY"]
    KCNK2["KCNK2"] -->|"encodes"| TREK1["TREK1"]
    Inflammation["Inflammation"] -->|"downregulates"| TREK1["TREK1"]
    PRNP["PRNP"] -->|"binds"| TREK1["TREK1"]
    PRIONPROTEINPRP["PRIONPROTEINPRP"] -->|"binds"| TREK1["TREK1"]
    style TREK1 fill:#4fc3f7,stroke:#333,color:#000

Structure and Gating

Channel Architecture

TREK1 is a K2P channel with unique structural features:

Four transmembrane domains: M1-M4
Two pore domains (P1 and P2): Form the potassium selectivity filter
Two extracellular loops: Between M1-P1 and M3-P2
N- and C-termini: Located intracellularly

Gating Mechanisms

TREK1 is uniquely regulated by multiple stimuli:

The channel has a large regulatory domain in the C-terminus that responds to mechanical, thermal, and chemical stimuli^[1].

Normal Function

Membrane Excitability

TREK1 provides background potassium conductance that:

Stabilizes resting membrane potential near K+ equilibrium potential
Sets input resistance and influences synaptic integration
Modulates action potential threshold
Provides dampening during repetitive firing

In cortical pyramidal neurons, TREK1 accounts for ~20% of the resting leak conductance^[2].

Neuroprotection

TREK1 plays a critical neuroprotective role:

Ischemic preconditioning: Activated during oxygen-glucose deprivation
Excitotoxicity: Reduces glutamate-induced neuronal death
Oxidative stress: Protects against ROS-mediated damage
Metabolic stress: Couples cellular energy status to excitability

The channel is upregulated in neurons following ischemic preconditioning, and genetic deletion of TREK1 increases infarct size in stroke models^[3].

Pain Transduction

In dorsal root ganglion (DRG) neurons:

Mechanosensation: TREK1/TRAAK detect mechanical stimuli
Nociception: Modulates pain sensitivity
Thermal sensation: Responds to temperature changes

TREK1 is downregulated in chronic pain states, contributing to hyperexcitability.

Psychiatric Disorders

Depression: TREK1 polymorphisms associated with major depressive disorder
Anxiety: Anxiolytic effects of TREK1 activation
Anesthesia: Target for volatile anesthetic agents

Role in Neurodegeneration

Stroke and Ischemia

TREK1 is a critical mediator of ischemic neuroprotection:

Preconditioning: Brief ischemia activates TREK1, providing tolerance
Excitotoxicity: Reduces Ca2+ influx through NMDA receptors
Blood-brain barrier: Protects endothelial function

KCNK2 knockout mice show increased neuronal death after focal ischemia, while TREK1 activators are protective^[4].

Alzheimer’s Disease

TREK1 alterations in AD include:

Amyloid-beta effects: Aβ reduces TREK1 current amplitude
Neuronal hyperexcitability: Contributes to network dysfunction
Calcium dysregulation: Indirect effects on calcium homeostasis

TREK1 dysfunction may contribute to the hyperexcitability observed in early AD.

Parkinson’s Disease

In PD models:

Dopaminergic neuron vulnerability: TREK1 expression altered in substantia nigra
Mitochondrial toxins: MPTP affects TREK1 function
Therapeutic potential: TREK1 activators may protect dopaminergic neurons

Epilepsy

TREK1 regulates neuronal excitability in epilepsy:

Seizure threshold: TREK1 loss-of-function lowers threshold
Status epilepticus: Altered expression following seizures
Therapeutic targeting: TREK1 activators as anticonvulsants

Amyotrophic Lateral Sclerosis

Motor neuron excitability: TREK1 contributes to hyperexcitability
Cortical involvement: Altered in upper motor neurons
Glial regulation: Astrocytic TREK1 affects neuronal support

Therapeutic Implications

Drug Development

Several approaches target TREK1:

Challenges

Blood-brain barrier penetration: Key challenge for CNS drugs
Selectivity: Developing selective activators
Ion homeostasis: Balancing excitation/inhibition

Interactions and Signaling

TREK1 interacts with multiple proteins:

KCNK4 (TRAAK): Co-expressed, complementary functions
PSD-95: Synaptic localization
Annexin A2: Mechanical coupling
PIP2: Membrane phospholipid regulation
Mecamylamine: Pharmacological modulation

Research Methods

Patch clamp: Direct current recording
FLIPR: High-throughput calcium screening
CRISPR: Genetic manipulation
Stroke models: MCAO in rodents

Key Publications

Honore E, et al. (2002). “The neuronal background of two-pore domain potassium channels.” Neuropharmacology. PMID:12126619.
Talley EM, et al. (2001). “Distribution of neuronal members of the K2P channel family.” J Comp Neurol. PMID:11464962.
Heurteaux C, et al. (2004). “TREK-1, a K+ channel involved in neuroprotection and general anesthesia.” EMBO J. PMID:15226251.
Wu X, et al. (2019). “TREK1 channel mediates neuroprotection in stroke.” J Cereb Blood Flow Metab. PMID:30296824.
Lotshaw DP. (2007). “Biophysical and pharmacological characterization of TASK-1 and TREK-1.” Am J Physiol. PMID:17209163.

External Links

Background

The study of Trek1 Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Pathway Diagram

The following diagram shows the key molecular relationships involving TREK1 Neurons discovered through SciDEX knowledge graph analysis:

graph TD
    KCNK2["KCNK2"] -->|"encodes"| TREK1["TREK1"]
    Inflammation["Inflammation"] -.->|"downregulates"| TREK1["TREK1"]
    FMRPPROTEIN["FMRPPROTEIN"] -->|"binds"| TREK1["TREK1"]
    PRIONPROTEINPRP["PRIONPROTEINPRP"] -->|"binds"| TREK1["TREK1"]
    PRNP["PRNP"] -->|"binds"| TREK1["TREK1"]
    GABAARECEPTORTHETAPROTEIN["GABAARECEPTORTHETAPROTEIN"] -->|"binds"| TREK1["TREK1"]
    RPS3A["RPS3A"] -->|"interacts with"| TREK1["TREK1"]
    style KCNK2 fill:#ce93d8,stroke:#333,color:#000
    style TREK1 fill:#4fc3f7,stroke:#333,color:#000
    style Inflammation fill:#4fc3f7,stroke:#333,color:#000
    style FMRPPROTEIN fill:#4fc3f7,stroke:#333,color:#000
    style PRIONPROTEINPRP fill:#4fc3f7,stroke:#333,color:#000
    style PRNP fill:#ce93d8,stroke:#333,color:#000
    style GABAARECEPTORTHETAPROTEIN fill:#4fc3f7,stroke:#333,color:#000
    style RPS3A fill:#ce93d8,stroke:#333,color:#000